144 related articles for article (PubMed ID: 34602286)
1. Incidence and treatment outcomes of ovarian sarcoma compared to epithelial ovarian cancer from the national cancer registry.
Ha HI; Cho SH; Lim J; Lee YJ; Yoo CW; Won YJ; Lim MC
Gynecol Oncol; 2021 Dec; 163(3):506-510. PubMed ID: 34602286
[TBL] [Abstract][Full Text] [Related]
2. Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.
Kim SI; Lim MC; Lim J; Won YJ; Seo SS; Kang S; Park SY
J Gynecol Oncol; 2016 Jan; 27(1):e5. PubMed ID: 26463436
[TBL] [Abstract][Full Text] [Related]
3. Incidence and treatment outcomes of ovarian carcinosarcoma from the national cancer registry of Korea.
Ha HI; Kim JH; Lim J; Song YJ; Won YJ; Lim MC
J Gynecol Oncol; 2024 Jan; 35(1):e31. PubMed ID: 38072401
[TBL] [Abstract][Full Text] [Related]
4. Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989-2015.
van der Hel OL; Timmermans M; van Altena AM; Kruitwagen RFPM; Slangen BFM; Sonke GS; van de Vijver KK; van der Aa MA
Eur J Cancer; 2019 Sep; 118():97-104. PubMed ID: 31326731
[TBL] [Abstract][Full Text] [Related]
5. Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis.
Schuurman MS; Timmermans M; van Gorp T; de Vijver KKV; Kruitwagen RFPM; Lemmens VEPP; van der Aa MA
Acta Oncol; 2019 Jul; 58(7):983-989. PubMed ID: 31135241
[No Abstract] [Full Text] [Related]
6. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and associated factors in patients with advanced epithelial ovarian cancer: a population-based study.
Zijlstra M; Timmermans M; Fransen H; van der Aa M; Reyners A; Raijmakers N; van de Poll-Franse L
Int J Gynecol Cancer; 2019 Jul; 29(6):1032-1037. PubMed ID: 31263022
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data.
Wieser S; Schmidt M; Kind AB; Heinzelmann-Schwarz VA
Swiss Med Wkly; 2018 Jul; 148():w14647. PubMed ID: 30141520
[TBL] [Abstract][Full Text] [Related]
9. Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.
Lee JY; Kim S; Kim YT; Lim MC; Lee B; Jung KW; Kim JW; Park SY; Won YJ
BMC Cancer; 2018 May; 18(1):601. PubMed ID: 29843633
[TBL] [Abstract][Full Text] [Related]
10. Management of rare epithelial ovarian cancers.
Gershenson DM
Clin Adv Hematol Oncol; 2019 Aug; 17(8):444-446. PubMed ID: 31449512
[No Abstract] [Full Text] [Related]
11. Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM).
Amadeo B; Penel N; Coindre JM; Ray-Coquard I; Ligier K; Delafosse P; Bouvier AM; Plouvier S; Gallet J; Lacourt A; Coureau G; Monnereau A; Mathoulin-Pélissier S; Desandes E
BMC Cancer; 2020 Mar; 20(1):190. PubMed ID: 32138705
[TBL] [Abstract][Full Text] [Related]
12. Patterns and progress in ovarian cancer over 14 years.
Chan JK; Cheung MK; Husain A; Teng NN; West D; Whittemore AS; Berek JS; Osann K
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):521-8. PubMed ID: 16946210
[TBL] [Abstract][Full Text] [Related]
13. Ovarian sarcoma carries a poorer prognosis than ovarian epithelial cancer throughout all FIGO stages: a single-center case-control matched study.
Bacalbasa N; Balescu I; Dima S; Popescu I
Anticancer Res; 2014 Dec; 34(12):7303-8. PubMed ID: 25503164
[TBL] [Abstract][Full Text] [Related]
14. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.
Lim MC; Won YJ; Ko MJ; Kim M; Shim SH; Suh DH; Kim JW
J Gynecol Oncol; 2019 Jan; 30(1):e38. PubMed ID: 30574686
[TBL] [Abstract][Full Text] [Related]
16. Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea.
Ouh YT; Kang D; Kim H; Lee JK; Hong JH
Sci Rep; 2021 May; 11(1):11158. PubMed ID: 34045639
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer incidence and survival in Korea: 1993-2002.
Chung HH; Hwang SY; Jung KW; Won YJ; Shin HR; Kim JW; Lee HP;
Int J Gynecol Cancer; 2007; 17(3):595-600. PubMed ID: 17300678
[TBL] [Abstract][Full Text] [Related]
18. Disparities in health-related quality of life in women undergoing treatment for advanced ovarian cancer: the role of individual-level and contextual social determinants.
Moss JL; Murphy J; Filiaci VL; Wenzel LB; Minasian L; Temkin SM
Support Care Cancer; 2019 Feb; 27(2):531-538. PubMed ID: 30003341
[TBL] [Abstract][Full Text] [Related]
19. Incidence of Cervical, Ovarian and Uterine Cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.
Medhin LB; Tekle LA; Achila OO; Said S
Sci Rep; 2020 Jun; 10(1):9099. PubMed ID: 32499531
[TBL] [Abstract][Full Text] [Related]
20. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999-2017.
Park M; Lim J; Lee JA; Park HJ; Park BK; Lim MC; Park SY; Won YJ
Gynecol Oncol; 2021 Oct; 163(1):79-84. PubMed ID: 34392955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
